Proteus syndrome: diagnostic criteria, differential diagnosis, and patient evaluation.

PubWeight™: 3.02‹?› | Rank: Top 1%

🔗 View Article (PMID 10360391)

Published in Am J Med Genet on June 11, 1999

Authors

L G Biesecker1, R Happle, J B Mulliken, R Weksberg, J M Graham, D L Viljoen, M M Cohen

Author Affiliations

1: Genetic Disease Research Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA.

Articles citing this

Protean PTEN: form and function. Am J Hum Genet (2002) 2.43

Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi (CLOVE) syndrome: CNS malformations and seizures may be a component of this disorder. Am J Med Genet A (2008) 2.17

Mosaic overgrowth with fibroadipose hyperplasia is caused by somatic activating mutations in PIK3CA. Nat Genet (2012) 1.74

PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation. Am J Med Genet A (2014) 1.31

Progressive overgrowth of the cerebriform connective tissue nevus in patients with Proteus syndrome. J Am Acad Dermatol (2010) 1.21

The lentiginoses: cutaneous markers of systemic disease and a window to new aspects of tumourigenesis. J Med Genet (2005) 1.07

Identification and molecular characterization of de novo translocation t(8;14)(q22.3;q13) associated with a vascular and tissue overgrowth syndrome. Cytogenet Cell Genet (2001) 1.00

Proteus syndrome: Clinical profile of six patients and review of literature. Indian J Hum Genet (2013) 0.99

Proteus syndrome: Clinical diagnosis of a series of cases. Indian J Endocrinol Metab (2013) 0.93

A limited form of proteus syndrome with bilateral plantar cerebriform collagenomas and varicose veins secondary to a mosaic AKT1 mutation. JAMA Dermatol (2014) 0.88

Imaging manifestations in Proteus syndrome: an unusual multisystem developmental disorder. Br J Radiol (2012) 0.88

Klippel-Trenaunay Syndrome: a case report with brief review of literature. J Dermatol Case Rep (2009) 0.88

Is the E133K allele of VG5Q associated with Klippel-Trenaunay and other overgrowth syndromes? J Med Genet (2006) 0.85

Bone malformations in Proteus syndrome: an analysis of bone structural changes and their evolution during growth. Pediatr Radiol (2007) 0.83

Cervical canal stenosis caused by progressive fusion and enlargement of cervical vertebrae with features of Proteus syndrome and Klippel-Feil syndrome. Skeletal Radiol (2013) 0.82

Differential diagnoses of overgrowth syndromes: the most important clinical and radiological disease manifestations. Radiol Res Pract (2014) 0.80

Perioperative respiratory complications caused by cystic lung malformation in Proteus syndrome. J Anesth (2006) 0.80

Imaging evaluation of fetal vascular anomalies. Pediatr Radiol (2014) 0.80

Radiographic manifestations of the temporomandibular joint in a case of Proteus syndrome. Dentomaxillofac Radiol (2012) 0.79

Proteus syndrome: A rare cause of gigantic limb. Indian Dermatol Online J (2014) 0.76

Orthopaedic manifestations of Proteus syndrome in a child with literature update. Bone Rep (2015) 0.75

Proteus syndrome: A rare case report. Indian J Hum Genet (2012) 0.75

Missense mutation in the PTEN promoter of a patient with hemifacial hyperplasia. Bonekey Rep (2015) 0.75

A case of concurrent proteus syndrome and hemophilia a. Iran J Pediatr (2012) 0.75

Proteus syndrome: report of intra-abdominal lipomatosis. European J Pediatr Surg Rep (2013) 0.75

Endometrioid Paraovarian Borderline Cystic Tumor in an Infant with Proteus Syndrome. Case Rep Oncol Med (2015) 0.75

Proteus syndrome: More vigilance needed to diagnose it. Indian J Endocrinol Metab (2014) 0.75

Proteus Syndrome with Arteriovenous Malformation. Adv Biomed Res (2017) 0.75

Excision of a large abdominal wall lipoma improved bowel passage in a Proteus syndrome patient. World J Gastroenterol (2009) 0.75

Hemispherectomy Procedure in Proteus Syndrome. Iran J Child Neurol (2016) 0.75

Hemilateral proteus syndrome: an unusual hamartomatous disorder with significant cerebellar tonsillar herniation. Indian J Dermatol (2015) 0.75

Genodermatosis Affecting the Skin and Mucosa of the Head and Neck: Clinicopathologic, Genetic, and Molecular Aspect-PTEN-Hamartoma Tumor Syndrome/Cowden Syndrome. Head Neck Pathol (2016) 0.75

Myocardial fat overgrowth in Proteus syndrome. Am J Med Genet A (2014) 0.75

Extending the spectrum of AKT1 mosaicism: not just the Proteus syndrome. Br J Dermatol (2016) 0.75

Proteus syndrome: evaluation of the immunological profile. Orphanet J Rare Dis (2016) 0.75

A review of vascular anomalies: genetics and common syndromes. Semin Plast Surg (2014) 0.75

Proteus syndrome: a case report and a case study review in China. Dermatol Reports (2010) 0.75

Proteus Syndrome with Neurological Manifestations: A Rare Presentation. J Pediatr Neurosci (2017) 0.75

Proteus syndrome with syringohydromyelia and arachnoid cyst. Childs Nerv Syst (2007) 0.75

A child with mental retardation and asymmetrical hypertrophy of limbs. Eur J Pediatr (2010) 0.75

Proteus syndrome revealing itself after the treatment of a bilateral subdural haematoma. Childs Nerv Syst (2013) 0.75

Somatic AKT1 mutations cause meningiomas colocalizing with a characteristic pattern of cranial hyperostosis. Am J Med Genet A (2016) 0.75

Articles by these authors

Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg (1982) 12.85

Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell (1997) 7.47

Characteristics of the BGM line of cells from African green monkey kidney. Brief report. Arch Gesamte Virusforsch (1970) 6.50

Coloboma, congenital heart disease, and choanal atresia with multiple anomalies: CHARGE association. J Pediatr (1981) 5.35

Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell (1996) 5.10

Incidence of fetal alcohol syndrome and prevalence of alcohol-related neurodevelopmental disorder. Teratology (1997) 4.86

Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med (1992) 4.76

Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. N Engl J Med (1989) 3.97

Syndromes with cleft lip and cleft palate. Cleft Palate J (1978) 3.84

The airway: problems and predictions in 18,500 patients. Can J Anaesth (1994) 3.46

Registries and administrative data: organization and accuracy. Med Care (1993) 3.44

Arteriovenous malformations of the head and neck: natural history and management. Plast Reconstr Surg (1998) 3.42

Lethal genes surviving by mosaicism: a possible explanation for sporadic birth defects involving the skin. J Am Acad Dermatol (1987) 3.40

A maternally methylated CpG island in KvLQT1 is associated with an antisense paternal transcript and loss of imprinting in Beckwith-Wiedemann syndrome. Proc Natl Acad Sci U S A (1999) 3.37

CHARGE association: an update and review for the primary pediatrician. Clin Pediatr (Phila) (1998) 3.33

PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome. Hum Mol Genet (1999) 3.22

Angelman and Prader-Willi syndromes share a common chromosome 15 deletion but differ in parental origin of the deletion. Am J Med Genet (1989) 3.22

Reliability of the timeline follow-back sexual behavior interview. Ann Behav Med (1998) 3.15

Sclerotherapy of craniofacial venous malformations: complications and results. Plast Reconstr Surg (1999) 2.99

Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest (1994) 2.97

Quantitative calibration and use of DNA probes for investigating chromosome abnormalities in the Prader-Willi syndrome. Am J Med Genet (1989) 2.83

Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy. JAMA (1994) 2.82

A mutation in the homeodomain of the human MSX2 gene in a family affected with autosomal dominant craniosynostosis. Cell (1993) 2.80

The Proteus syndrome: the Elephant Man diagnosed. Br Med J (Clin Res Ed) (1986) 2.73

Hemangiomas and vascular malformations of infancy and childhood. Pediatr Clin North Am (1993) 2.69

Establishment in continuous culture of a new type of lymphocyte from a "Burkitt like" malignant lymphoma (line D.G.-75). Int J Cancer (1977) 2.66

What every dermatologist should know about homeopathy. Arch Dermatol (1996) 2.59

Vascular tumors and vascular malformations (new issues). Adv Dermatol (1997) 2.48

Predicting difficult intubation: a multivariable analysis. Can J Anaesth (2000) 2.41

In vivo and in vitro chromosomal damage induced by LSD-25. N Engl J Med (1967) 2.39

Testing the raters: inter-rater reliability of standardized anaesthesia simulator performance. Can J Anaesth (1997) 2.37

Craniosynostoses: phenotypic/molecular correlations. Am J Med Genet (1995) 2.35

GLI3 frameshift mutations cause autosomal dominant Pallister-Hall syndrome. Nat Genet (1997) 2.28

EBV transformation and cell culturing destabilizes DNA methylation in human lymphoblastoid cell lines. Genomics (2009) 2.26

A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome. Am J Hum Genet (1997) 2.22

Colon and rectal anastomoses do not require routine drainage: a systematic review and meta-analysis. Ann Surg (1999) 2.20

Congenital vascular lesions: clinical application of a new classification. J Pediatr Surg (1983) 2.20

Clonality and altered behavior of endothelial cells from hemangiomas. J Clin Invest (2001) 2.20

Evaluation of mental retardation: recommendations of a Consensus Conference: American College of Medical Genetics. Am J Med Genet (1997) 2.19

Clinical and molecular studies in full trisomy 22: further delineation of the phenotype and review of the literature. Am J Med Genet (1995) 2.15

Why is there no progress against cervical cancer? CMAJ (1996) 2.14

Nonsyndromic cleft lip with or without cleft palate: evidence of linkage to BCL3 in 17 multigenerational families. Am J Hum Genet (1995) 2.12

Antiangiogenic therapy of a recurrent giant cell tumor of the mandible with interferon alfa-2a. Pediatrics (1999) 2.12

Is there a Baller-Gerold syndrome? Am J Med Genet (1996) 2.11

Restriction fragment length polymorphisms within proximal 15q and their use in molecular cytogenetics and the Prader-Willi syndrome. Am J Med Genet (1989) 2.00

A new syndrome with hypotonia, obesity, mental deficiency, and facial, oral, ocular, and limb anomalies. J Pediatr (1973) 1.98

Complementary therapies: have they become accepted in general practice? Med J Aust (2000) 1.98

The McCune-Albright syndrome: a lethal gene surviving by mosaicism. Clin Genet (1986) 1.98

The anesthetic record: accuracy and completeness. Can J Anaesth (1999) 1.96

Pyogenic granuloma (lobular capillary hemangioma): a clinicopathologic study of 178 cases. Pediatr Dermatol (1991) 1.96

Testing internal consistency and construct validity during evaluation of performance in a patient simulator. Anesth Analg (1998) 1.95

Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancy. J Pediatr (1998) 1.95

Application of the biological principle of induced osteogenesis for craniofacial defects. Lancet (1981) 1.92

A newly recognized hamartomatous syndrome. Birth Defects Orig Artic Ser (1979) 1.89

Splicing mutations of 54-bp exons in the COL11A1 gene cause Marshall syndrome, but other mutations cause overlapping Marshall/Stickler phenotypes. Am J Hum Genet (1999) 1.88

Laparoscopic loop ileostomy for temporary fecal diversion. Dis Colon Rectum (1993) 1.88

Lyonization and the lines of Blaschko. Hum Genet (1985) 1.86

Measuring patient satisfaction with anesthesia care: a review of current methodology. Anesth Analg (1998) 1.86

Analysis of phenotypic features and FGFR2 mutations in Apert syndrome. Am J Hum Genet (1995) 1.85

Germline and germline mosaic PTEN mutations associated with a Proteus-like syndrome of hemihypertrophy, lower limb asymmetry, arteriovenous malformations and lipomatosis. Hum Mol Genet (2000) 1.84

The location of proteins labeled by the 125I-lactoperoxidase system in the NIL 8 hamster fibroblast. Cell (1975) 1.84

Assignment of a locus for dominantly inherited venous malformations to chromosome 9p. Hum Mol Genet (1994) 1.83

Angelman syndrome: three molecular classes identified with chromosome 15q11q13-specific DNA markers. Am J Hum Genet (1990) 1.83

Comparing clinical information with claims data: some similarities and differences. J Clin Epidemiol (1991) 1.83

Soft-tissue vascular anomalies: utility of US for diagnosis. Radiology (2000) 1.82

Autosomal dominant craniometaphyseal dysplasia is caused by mutations in the transmembrane protein ANK. Am J Hum Genet (2001) 1.81

A survey of 112,000 anaesthetics at one teaching hospital (1975-83). Can Anaesth Soc J (1986) 1.81

22q11 deletion syndrome in adults with schizophrenia. Am J Med Genet (1998) 1.79

Thrombocytopenic coagulopathy (Kasabach-Merritt phenomenon) is associated with Kaposiform hemangioendothelioma and not with common infantile hemangioma. Plast Reconstr Surg (1997) 1.76

Cytokine mRNA levels in Alopecia areata before and after treatment with the contact allergen diphenylcyclopropenone. J Invest Dermatol (1994) 1.76

A comparison of the analgesic efficacy and side-effects of paravertebral vs epidural blockade for thoracotomy--a systematic review and meta-analysis of randomized trials. Br J Anaesth (2006) 1.75

A spectrum of ABCC6 mutations is responsible for pseudoxanthoma elasticum. Am J Hum Genet (2001) 1.73

Unbalanced placental expression of imprinted genes in human intrauterine growth restriction. Placenta (2005) 1.73

Superimposed lateralized exanthem of childhood: report of a case related to adenovirus infection. Clin Exp Dermatol (2014) 1.73

The Saethre-Chotzen syndrome. Birth Defects Orig Artic Ser (1975) 1.72

Klippel-Trenaunay syndrome. Am J Med Genet (2000) 1.72

Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease. Am J Hum Genet (1996) 1.70

FGFR2 exon IIIa and IIIc mutations in Crouzon, Jackson-Weiss, and Pfeiffer syndromes: evidence for missense changes, insertions, and a deletion due to alternative RNA splicing. Am J Hum Genet (1996) 1.70

Bannayan-Riley-Ruvalcaba syndrome. Am J Med Genet (1992) 1.69

Donor-site morbidity after harvesting rib and iliac bone. Plast Reconstr Surg (1984) 1.67

Craniosynostosis and syndromes with craniosynostosis: incidence, genetics, penetrance, variability, and new syndrome updating. Birth Defects Orig Artic Ser (1979) 1.67

Induction of hair growth in alopecia areata with D.N.C.B. Lancet (1977) 1.66

The incidence of airway problems depends on the definition used. Can J Anaesth (1996) 1.65

Childhood hemangiomas and vascular malformations: angiographic differentiation. AJR Am J Roentgenol (1983) 1.64

Type 2 segmental Cowden disease vs. Proteus syndrome. Br J Dermatol (2007) 1.63

Holoprosencephaly and cytogenetic findings: further information. Am J Med Genet (1989) 1.63

Frontonasal dysplasia. J Pediatr (1970) 1.62

An etiologic and nosologic overview of craniosynostosis syndromes. Birth Defects Orig Artic Ser (1975) 1.62

Localization of the gene encoding the GABAA receptor beta 3 subunit to the Angelman/Prader-Willi region of human chromosome 15. Am J Hum Genet (1991) 1.62

The chromosomal constitution of 165 human translocations involving D group chromosomes identified by autoradiography. Ann Genet (1971) 1.61

The incorporation of steroid molecules into lecithin sols, beta-lipoproteins and cellular membranes. Eur J Biochem (1968) 1.61

A gene for familial venous malformations maps to chromosome 9p in a second large kindred. J Med Genet (1995) 1.59

Cutaneous manifestation of lethal genes. Hum Genet (1986) 1.59

Vascular anomalies of the maxillofacial region. J Oral Maxillofac Surg (1986) 1.57

Ampicillin in the treatment of Listeria monocytogenes meningitis. Lancet (1968) 1.57

Treatment of alopecia areata with diphenylcyclopropenone. J Am Acad Dermatol (1991) 1.56

Cutis marmorata telangiectatica congenita and extensive mongolian spots: type 5 phacomatosis pigmentovascularis. Br J Dermatol (2003) 1.56

Bayes factor of model selection validates FLMP. Psychon Bull Rev (2001) 1.55

Tests of auditory-visual integration efficiency within the framework of the fuzzy logical model of perception. J Acoust Soc Am (2000) 1.55